Reference interval and the role of plasma oligomeric beta amyloid in screening of risk groups for cognitive dysfunction at health checkups

BACKGROUND: Alzheimer's disease (AD) has a prolonged preclinical stage characterized by cognitive dysfunction. Simple, reliable, and noninvasive biomarkers reflecting the pathogenesis of AD are needed for screening cognitive dysfunction in primary health care. The aims of this study were to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Nah, Eun‐Hee, Cho, Seon, Park, Hyeran, Noh, Dongwon, Hwang, Inhwan, Cho, Han‐Ik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418474/
https://www.ncbi.nlm.nih.gov/pubmed/34342379
http://dx.doi.org/10.1002/jcla.23933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418474/
https://www.ncbi.nlm.nih.gov/pubmed/34342379
http://dx.doi.org/10.1002/jcla.23933

Ejemplares similares